2025年11月6日,分析人员修订了股票评级和目标,发布了若干降级和1个买入评级。 On Nov. 6, 2025, analysts revised stock ratings and targets, with several downgrades and one buy rating issued.

2025年11月6日,分析师调整了多个库存的评级和价格目标。 On November 6, 2025, analysts adjusted ratings and price targets for multiple stocks. 美国的 ACV 拍卖公司被巴林顿研究公司降级为市场表现,目标降至 6.00 美元. ACV Auctions was downgraded to market perform by Barrington Research, with its target reduced to $6.00. ACADIA制药公司虽然收入丰厚,但加拿大皇家银行将其目标降至32.00美元。 ACADIA Pharmaceuticals saw its target lowered to $32.00 by Royal Bank of Canada, despite strong earnings. Aident、Alight、Alpha和Omega半导体面临下调。 Adient, Alight, and Alpha and Omega Semiconductor faced downward revisions. ARM得到了Rosenblatt的买入评级,而ArcBest和Everl源能源则被降级。 ARM received a buy rating from Rosenblatt, while ArcBest and Eversource Energy were downgraded. 一些公司重申或启动了对Apellis制药公司、放大公司和Fortinet公司等公司的覆盖,并进行了各种目标变化。 Several firms reaffirmed or initiated coverage on companies like Apellis Pharmaceuticals, Amplitude, and Fortinet, with various target changes.